Teligent Announces Second Quarter 2017 Results
BUENA, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2017.
Second Quarter 2017 Highlights
Total revenues of $18.4 million in the second quarter of 2017, an increase of 7% over the same quarter in 2016.
Second Quarter 2017 Highlights
Total revenues of $18.4 million in the second quarter of 2017, an increase of 7% over the same quarter in 2016.